Related Experiment Video

Updated: Sep 26, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

5.8K

Stem-Cell Therapy for Bronchopulmonary Dysplasia (BPD) in Newborns

Said A Omar1,2, Amal Abdul-Hafez1, Sherif Ibrahim1

  • 1Division of Neonatology, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State University, East Lansing, MI 48824, USA.

Cells
|April 23, 2022
PubMed

Insights

Mesenchymal stem cells (MSCs) and their derived extracellular vesicles (EVs) show promise for treating premature infants with bronchopulmonary dysplasia (BPD). These stem-cell therapies may reduce lung inflammation and improve lung structure, offering new hope for infants with this condition.

Area of Science:

  • Neonatal Medicine
  • Regenerative Medicine
  • Pulmonology

Background:

  • Premature infants face high risks of respiratory distress syndrome (RDS) and bronchopulmonary dysplasia (BPD), leading to severe long-term complications.
  • Current BPD treatments are supportive, including high-oxygen and pharmacotherapy, highlighting the need for novel therapeutic strategies.
  • Reduced resident stem cells in BPD lungs suggest a critical role for stem cells in disease pathogenesis.

Purpose of the Study:

  • To explore the potential of stem-cell-based therapies for treating bronchopulmonary dysplasia (BPD) in premature infants.
  • To investigate the efficacy of mesenchymal stem cells (MSCs) and their derived extracellular vesicles (EVs) as therapeutic modalities for BPD.
  • To identify potential benefits of MSCs and EVs in improving lung health and reducing BPD-related complications.

Main Methods:

  • Review of current literature on stem-cell-based therapies for acute lung injury and BPD.
  • Analysis of the role of mesenchymal stem cells (MSCs) and extracellular vesicles (EVs) in preclinical and clinical studies.
  • Evaluation of the impact of MSCs and EVs on key BPD pathological features.

Main Results:

  • Mesenchymal stem cells (MSCs) and MSC-derived extracellular vesicles (EVs), including exosomes, demonstrate significant therapeutic potential for BPD.
  • Treatment with MSCs and EVs has been shown to reduce lung inflammation and improve pulmonary architecture.
  • These stem-cell-based approaches may attenuate pulmonary fibrosis and enhance survival rates in BPD models.

Conclusions:

  • Mesenchymal stem cells (MSCs) and extracellular vesicles (EVs) represent promising therapeutic options for bronchopulmonary dysplasia (BPD).
  • These regenerative medicine approaches offer a potential to improve lung development and reduce long-term adverse outcomes in premature infants.
  • Further research into MSCs and EVs is warranted to optimize their clinical application for BPD treatment.

Keywords:
bronchopulmonary dysplasiaextracellular vesicleshyperoxialung injurypremature infantsstem cells

More Related Videos

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease04:21

A Minimally Invasive Method for Intratracheal Instillation of Drugs in Neonatal Rodents to Treat Lung Disease

Published on: August 4, 2021

6.2K
Tracheotomy: A Method for Transplantation of Stem Cells to the Lung03:45

Tracheotomy: A Method for Transplantation of Stem Cells to the Lung

Published on: February 25, 2007

11.9K

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.5K